As M&A costs rise, new Accenture report offers alternative strategies July 1, 2022 Auto Bot Accenture, BioPharma, biopharma nl, M&A, Mergers and Acquisitions, News, Pfizer, Sanofi 0 Rising deal premiums and shrinking profit margins are threatening the sustainability of the traditional approach to mergers and acqusitions, according to a report by Accenture. The firm expects growth-minded companies will turn to other pathways.